MagPro R30 incl. MagOption, MagPro X100 and MagPro X100 incl. MagOption are Magnetic stimulators used for Magnetic stimulation. These three devices are, together with the predicate device MagPro R30, called "MagPro Family". Hereafter we name the three devices in this submission "the new devices". Magnetic stimulation is a non-invasive technique for stimulating neural tissue. Application areas of magnetic stimulation are a sub-set of the application areas for current stimulation. The new devices are connected to a Magnetic Coil which transfers the magnetic stimulation to the tissue. All Standard coils as well as the Fluid and Cool coils can be used with the MagPro devices, (K926516, K061645, K071821). The new devices are magnetic stimulators, featuring Biphasic, Monophasic, Halfsine, Biphasic Burst waveform, stimulation rates up to 100 pulses per second (pps), stimulus sequences and protocols controlled via a built-in computer and 8,4" display.

AI/ML Overview

This 510(k) premarket notification is for magnetic stimulators (MagPro R30, X100, and variants) and does not contain information typically associated with AI/ML device studies. The submission focuses on demonstrating substantial equivalence to predicate devices, primarily through technological comparison and compliance with existing medical device standards rather than clinical performance metrics in the context of an algorithmic decision.

Therefore, the requested information regarding acceptance criteria, device performance tables, sample sizes, ground truth establishment, expert qualifications, adjudication methods, and MRMC studies is not applicable to this specific 510(k) submission.

The document indicates that the devices are for "stimulation of peripheral nerves for diagnostic purposes" and that "The difference in performance between the new devices and the predicate devices are thoroughly compared and discussed in the 'Substantial Equivalence' section." However, this section (not fully provided in the input) would likely focus on electrical and magnetic output characteristics, safety, and functional equivalence, not diagnostic accuracy in the way an AI/ML device would be assessed.

The submission concludes that "The new devices do not raise new issues of safety and effectiveness and are substantially equivalent to the predicate devices." This is the primary "acceptance criterion" for a 510(k) of this nature.

Summary

{0}------------------------------------------------

510(k)

. .

Ko91940

MagPro R30 incl. MagOption, X100, X100 incl. MagOption

510(k) Summary

Name of 510(k) owner:	Tonica Elektronik A/SLucernemarken 15DK-3520 FarumDenmark
Phone:	+45 4499 8444
Fax:	+45 4499 1544
Contact:	Lise Terkelsen
Preparation date:	June 19, 2009
Trade name:	MagPro R30 incl. MagOptionMagPro X100MagPro X100 incl. MagOption
Common name:	MagPro R30 incl. MagOptionMagPro X100MagPro X100 incl. MagOption
Classification name:	Evoked Response Electrical Stimulator
Identification of predicate devices:	MagPro R30, K061645MagPro, K926516Magstim Super Rapid², K051864Keypoint (K944547)Digitimer DS7A (K051357)

MAR 2 6 2010ﺘﺮ

{1}------------------------------------------------

MagPro R30 incl. MagOption, X100, X100 incl. MagOption

Device description

Magnetic stimulation is a non-invasive technique for stimulating neural tissue. Application areas of magnetic stimulation are a sub-set of the application areas for current stimulation.

The new devices are connected to a Magnetic Coil which transfers the magnetic stimulation to the tissue. All Standard coils as well as the Fluid and Cool coils can be used with the MagPro devices, (K926516, K061645, K071821).

The new devices are magnetic stimulators, featuring Biphasic, Monophasic, Halfsine, Biphasic Burst waveform, stimulation rates up to 100 pulses per second (pps), stimulus sequences and protocols controlled via a built-in computer and 8,4" display.

Intended Use:

The magnetic stimulators are intended to be used for stimulation of peripheral nerves for diagnostic purposes.

Substantial Equivalence:

The new devices in this submission have the same characteristics as the predicate devices, MagPro R30 (K061645), MagPro (K926516) and Magstim Super Rapid² (K051864). Stimulation of peripheral nerves is the intended application which applies for all these magnetic stimulator devices.

They consist of a unit comprising power electronic to generate the magnetic fields in a Magnetic Coil. All includes a user interface to control the device via knobs or touch screen and a display on the front panel.

The difference in performance between the new devices and the predicate devices are thoroughly compared and discussed in the "Substantial Equivalence" section. Evidence for the higher repetition rate of 100pps is documented and found substantial equivalent to current stimulators, Keypoint (K944547) and Digitimer DS7A (K051357), which are able to perform at more powerful repetition rates.

The new devices are CE-marked and comply with the Medical Device Directive 93/42/EEC and also the Canadian CMDR. The new devices are developed and manufactured according to EN13485, "Medical devices - Quality management systems -Requirement for regulatory purposes". The new devices comply with the standard for electrical safety standard, IEC 60601-1, and have been tested at a certified test center, UL Demko. EMC testing has been performed for compliance with the EMC standard, IEC 60601-1-2. The MagPro devices fulfill the requirements in the standard IEC 60601-1-6 Usability.

{2}------------------------------------------------

MagPro R30 incl. MagOption, X100, X100 incl. MagOption

Conclusion:

ﺍﻟﻤﺘﺤﺪﺓ ﺍﻟﻤﺘﺤﺪﺓ ﺍﻟﻤﺘﺤﺪﺓ ﺍﻟﻤﺘﺤﺪﺓ ﺍﻟﻤﺘﺤﺪﺓ ﺍﻟﻤﺘﺤﺪﺓ ﺍﻟﻤﺘﺤﺪﺓ ﺍﻟﻤﺘﺤﺪﺓ ﺍﻟﻤﺘﺤﺪﺓ ﺍﻟﻤﺘﺤﺪﺓ ﺍﻟﻤﺘﺤﺪﺓ ﺍﻟﻤﺘﺤﺪﺓ ﺍﻟﻤﺘﺤﺪﺓ ﺍﻟﻤﺘﺤﺪﺓ ﺍﻟﻤﺘﺤﺪﺓ ﺍﻟﻤﺘﺤﺪﺓ ﺍﻟﻤﺘﺤﺪﺓ ﺍﻟﻤﺘﺤﺪﺓ ﺍﻟﻤﺘﺤﺪﺓ ﺍﻟﻤﺘﺤﺪﺓ ﺍﻟﻤﺘﺤﺪﺓ ﺍﻟﻤﺘﺤ

The MagPro R30 incl. MagOption, MagPro X100 and MagPro X100 incl. MagOption have the same intended use as the predicate magnetic stimulator devices and the same technological features. The difference in performance is shown equivalent to various predicate devices.

The new devices do not raise new issues of safety and effectiveness and are substantially equivalent to the predicate devices.

{3}------------------------------------------------

Image /page/3/Picture/1 description: The image shows the logo for the Department of Health & Human Services USA. The logo features a stylized eagle with three stripes forming its wing, and the text "DEPARTMENT OF HEALTH & HUMAN SERVICES USA" is arranged in a circular pattern around the eagle. The logo is black and white.

Food and Drug Administration 10903 New Hampshire Avenue Document Mail Center - WO66-G609 Silver Spring, MD 20993-0002

Tonica Elektronik A/S c/o Ms. Lise Terkelsen Lucernemarken 15 DK-3520 Farum Denmark

MAR 2 6 2010

Re: K091940

Trade/Device Name: MagPro R30 with Magoption, MagPro X100, and MagPro X100 with MagOption Regulation Number: 21 CFR 882.1870

Regulation Name: Evoked Response Electrical Stimulator Regulatory Class: Class II Product Code: GWF Dated: March 15, 2010 Received: March 18, 2010

Dear Ms. Terkelsen:

We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the includions for use stated in the enclosure) to legally marketed predicate devices marketed in intestate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendmonts, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Dr to and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA), You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, into not devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not mastering.

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.

{4}------------------------------------------------

Page 2 - Ms. Lise Terkelsen

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.

If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please go to http://www.fda.gov/AboutFDA/CentersOffices/CDRH/CDRHOffices/ucm 1 1 5809.htm for the Center for Devices and Radiological Health's (CDRH's) Office of Compliance. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to

http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.

You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address

http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm.

Sincerely yours,

Malvina B. Eydelman, M. Director Division of Ophthalmic, Neurological, and Ear, Nose and Throat Devices Office of Device Evaluation Center for Devices and Radiological Health

Enclosure

{5}------------------------------------------------

510(k) number: K091940

Div/Branch	Last Name	Date
DONEDINNOB	HUTTER	25MARC

For Office of Compliance Contact Information:

http://insideport.lets.fda.gov:9010/portal/page?_pageid=197,415881&_dad=portal&_schema=PO RTAL&org=318

For Office of Surveillance and Biometrics Contact Information:

http://insideportlets.fda.gov:9010/portal/page?_pageid=197,415881&_dad=portal&_schema=PO RTAL&org=423

Date of Update	By	Description of Update
7/27/09	Brandi Stuart	Added Updates to Boiler Table
8/7/09	Brandi Stuart	Updated HFZ Table
1/11/10	Diane Garcia	Liability/Warranty sentence added at bottom of 1st page

Drafted: Joseph Hutter, Ph.D. Edited: Final: Typed: Marisol Lendor, March 25, 2010

{6}------------------------------------------------

MagPro R30 incl. MagOption, X100, X100 incl. MagOption

Indications for Use

510(k) Number (if known):

Device Name:

Indications for Use:

MagPro R30 with MagOption MagPro X100 MagPro X100 with MagOption

The devices are intended to be used for stimulation of peripheral nerves for diagnostic purposes.

Prescription Use X (Part 21 CFR 801 Subpart D)

and/or Over-The-Counter Use (Part 21 CFR 801 Subpart C)

JOE HUTTER

(Division Sign-Off) Division of Ophthalmic, Neurological and Ear, Nose and Throat Devices

· ' ^/k) Number.

K091940

Regulation Number and Section

§ 882.1870 Evoked response electrical stimulator.

(a)
Identification. An evoked response electrical stimulator is a device used to apply an electrical stimulus to a patient by means of skin electrodes for the purpose of measuring the evoked response.(b)
Classification. Class II (performance standards).